Due to the molecular heterogeneity in AML, genetic abnormalities can vary between individual cases of leukemia, and there may be rare cases where JAK1, PDGFRA and FGFR2 abnormalities are present in CBF-AML. The gene discussed is FGFR2; the disease is leukemia.